Ex/FW
vivo/FW
activation/NN
of/IN
tumor-draining/JJ
lymph/NN
node/NN
T/NN
cells/NNS
reverses/VBZ
defects/VBZ
in/IN
signal/NN
transduction/NN
molecules/NNS
./.

The/DT
adoptive/JJ
transfer/NN
of/IN
tumor-draining/JJ
lymph/NN
node/NN
(/(
LN/NN
)/)
T/NN
cells/NNS
activated/VBD
ex/FW
vivo/FW
with/IN
anti-CD3/NN
and/CC
interleukin/NN
2/CD
(/(
IL-2/NN
)/)
mediates/VBZ
the/DT
regression/NN
of/IN
the/DT
poorly/RB
immunogenic/JJ
murine/JJ
melanoma/NN
D5/NN
./.
=====
The/DT
efficacy/NN
of/IN
the/DT
activated/VBN
LN/NN
cells/NNS
is/VBZ
augmented/VBN
when/WRB
the/DT
sensitizing/VBG
tumor/NN
is/VBZ
a/DT
genetically/RB
modified/VBN
variant/NN
(/(
designated/VBN
D5G6/NN
)/)
that/WDT
secretes/VBZ
granulocyte/macrophage-colony-stimulating/JJ
factor/NN
./.
=====
In/IN
contrast/NN
to/TO
anti-CD3/IL-2-activated/JJ
LN/NN
cells/NNS
,/,
adoptive/JJ
transfer/NN
of/IN
freshly/RB
isolated/VBN
tumor-draining/JJ
LN/NN
T/NN
cells/NNS
has/VBZ
no/DT
therapeutic/JJ
activity/NN
./.
=====
To/TO
determine/VB
whether/IN
the/DT
acquisition/NN
of/IN
antitumor/JJ
function/NN
during/IN
ex/FW
vivo/FW
activation/NN
is/VBZ
associated/VBN
with/IN
modifications/NNS
in/IN
signal/NN
transduction/NN
capacity/NN
,/,
the/DT
protein/NN
tyrosine/NN
kinases/NNS
p56lck/NN
and/CC
p59fyn/NN
and/CC
proteins/NNS
of/IN
the/DT
NF-kappaB/NN
family/NN
were/VBD
analyzed/VBN
in/IN
tumor-draining/JJ
LN/NN
T/NN
cells/NNS
./.
=====
The/DT
levels/NNS
of/IN
p56lck/NN
and/CC
p59fyn/NN
were/VBD
lower/JJR
in/IN
tumor-draining/JJ
than/IN
in/IN
normal/JJ
LN/NN
T/NN
cells/NNS
and/CC
production/NN
of/IN
tyrosine-phosphorylated/JJ
substrates/NNS
was/VBD
markedly/RB
depressed/VBN
following/VBG
anti-CD3/JJ
stimulation/NN
./.
=====
After/IN
5-day/JJ
anti-CD3/IL-2/JJ
activation/NN
,/,
levels/NNS
of/IN
p56lck/NN
and/CC
p59fyn/NN
and/CC
protein/NN
tyrosine/NN
kinase/NN
activity/NN
increased/VBN
./.
=====
Interestingly/RB
,/,
the/DT
levels/NNS
of/IN
p56lck/NN
,/,
p59fyn/NN
,/,
and/CC
tyrosine/NN
kinase/NN
activity/NN
were/VBD
higher/JJR
in/IN
activated/VBN
T/NN
cells/NNS
derived/VBN
from/IN
LN/NN
that/IN
drained/VBD
D5G6/NN
than/IN
they/PRP
were/VBD
in/IN
those/DT
from/IN
D5/NN
tumors/NNS
./.
=====
In/IN
contrast/NN
,/,
the/DT
cytoplasmic/JJ
levels/NNS
of/IN
c-Rel/NN
and/CC
Rel/NN
A/NN
were/VBD
normal/JJ
in/IN
freshly/RB
isolated/VBN
tumor-draining/JJ
LN/NN
,/,
as/IN
was/VBD
nuclear/JJ
kappaB/NN
DNA-binding/JJ
activity/NN
induced/VBN
by/IN
anti-CD3/JJ
mAb/NN
or/CC
phorbol/NN
myristate/NN
acetate/NN
./.
=====
Stimulation/NN
of/IN
activated/VBN
LN/NN
cells/NNS
with/IN
D5/NN
tumor/NN
cells/NNS
induced/VBD
the/DT
nuclear/JJ
translocation/NN
of/IN
NF-kappaB/NN
./.
=====
These/DT
findings/NNS
indicate/VBP
that/IN
the/DT
recovery/NN
of/IN
proteins/NNS
mediating/VBG
signal/NN
transduction/NN
through/IN
the/DT
T/NN
cell/NN
receptor/CD3/NN
complex/NN
in/IN
LN/NN
T/NN
cells/NNS
activated/VBD
ex/FW
vivo/FW
was/VBD
associated/VBN
with/IN
the/DT
acquisition/NN
of/IN
antitumor/JJ
function/NN
./.